Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 200K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Tobery, T. W. Articles by Siliciano, R. F. Search for Related Content PubMed PubMed Citation Articles by Tobery, T. W. Articles by Siliciano, R. F. Social Bookmarking                            What's this?

Articles

From the Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

CD8⁺ cytotoxic T lymphocytes (CTLs) have the ability to recognize and eliminate virally infected cells before new virions are produced within that cell. Therefore, a rapid and vigorous CD8⁺ CTL response, induced by vaccination, can, in principle, prevent disseminated infection in vaccinated individuals who are exposed to the relevant virus. There has thus been interest in novel vaccine strategies that will enhance the induction of CD8⁺ CTLs. In this study, we have tested the hypothesis that targeting an antigen to undergo more efficient processing by the class I processing pathway will elicit a more vigorous CD8⁺ CTL response against that antigen. Targeting a type I transmembrane protein, the HIV-1 envelope (env) protein, for expression in the cytoplasm, rather than allowing its normal co-translational translocation into the endoplasmic reticulum, sensitized target cells expressing this mutant more rapidly for lysis by an env-specific CTL clone. Additionally, a greatly enhanced de novo env-specific CTL response was induced in vivo after immunization of mice with recombinant vaccinia vectors expressing the cytoplasmic env mutant. Similarly, targeting a cytoplasmic protein, HIV-1 nef, to undergo rapid cytoplasmic degradation induced a greatly enhanced de novo nef-specific CD8⁺ CTL response in vivo after immunization of mice with either recombinant vaccinia vectors or DNA expression plasmids expressing the degradation targeted nef mutant. The targeting of viral antigens for rapid cytoplasmic degradation represents a novel and highly effective vaccine strategy for the induction of enhanced de novo CTL responses in vivo.

¹Abbreviations used in this paper: β-gal, β-galactosidase; env, envelope; HA, hemagglutinin; MOI, multiplicity of infection; NP, nucleoprotein; O/N, overnight; SIV, simian immunodeficiency virus; ss–, signal sequence minus; Ub, ubiquitin; vac, vaccinia; wt, wild type.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Jeon, Y. H., Choi, Y., Yoon, S. O., Kim, C. W., Chung, J.-K. (2008). Synergistic tumoricidal effect of combined hMUC1 vaccination and hNIS radioiodine gene therapy. Molecular Cancer Therapeutics 7: 2252-2260 [Abstract] [Full Text]  
• Goldwich, A., Hahn, S. S. C., Schreiber, S., Meier, S., Kampgen, E., Wagner, R., Lutz, M. B., Schubert, U. (2008). Targeting HIV-1 Gag into the Defective Ribosomal Product Pathway Enhances MHC Class I Antigen Presentation and CD8+ T Cell Activation. J. Immunol. 180: 372-382 [Abstract] [Full Text]  
• Delmas, S., Martin, L., Baron, M., Nelson, J. A., Streblow, D. N., Davignon, J.-L. (2005). Optimization of CD4+ T Lymphocyte Response to Human Cytomegalovirus Nuclear IE1 Protein through Modifications of Both Size and Cellular Localization. J. Immunol. 175: 6812-6819 [Abstract] [Full Text]  
• Milicic, A., Price, D. A., Zimbwa, P., Booth, B. L., Brown, H. L., Easterbrook, P. J., Olsen, K., Robinson, N., Gileadi, U., Sewell, A. K., Cerundolo, V., Phillips, R. E. (2005). CD8+ T Cell Epitope-Flanking Mutations Disrupt Proteasomal Processing of HIV-1 Nef. J. Immunol. 175: 4618-4626 [Abstract] [Full Text]  
• Huang, Y., Fayad, R., Smock, A., Ullrich, A. M., Qiao, L. (2005). Induction of Mucosal and Systemic Immune Responses against Human Carcinoembryonic Antigen by an Oral Vaccine. Cancer Res. 65: 6990-6999 [Abstract] [Full Text]  
• Golovina, T. N., Morrison, S. E., Eisenlohr, L. C. (2005). The Impact of Misfolding versus Targeted Degradation on the Efficiency of the MHC Class I-Restricted Antigen Processing. J. Immunol. 174: 2763-2769 [Abstract] [Full Text]  
• Singh, R. A. K., Barry, M. A. (2004). Repertoire and Immunofocusing of CD8 T Cell Responses Generated by HIV-1 gag-pol and Expression Library Immunization Vaccines. J. Immunol. 173: 4387-4393 [Abstract] [Full Text]  
• Wong, S. B. J., Buck, C. B., Shen, X., Siliciano, R. F. (2004). An Evaluation of Enforced Rapid Proteasomal Degradation as a Means of Enhancing Vaccine-Induced CTL Responses. J. Immunol. 173: 3073-3083 [Abstract] [Full Text]  
• Wang, Z., La Rosa, C., Mekhoubad, S., Lacey, S. F., Villacres, M. C., Markel, S., Longmate, J., Ellenhorn, J. D. I., Siliciano, R. F., Buck, C., Britt, W. J., Diamond, D. J. (2004). Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells. Blood 104: 847-856 [Abstract] [Full Text]  
• Shen, L., Rock, K. L. (2004). Cellular protein is the source of cross-priming antigen in vivo. Proc. Natl. Acad. Sci. USA 101: 3035-3040 [Abstract] [Full Text]  
• Daftarian, P., Ali, S., Sharan, R., Lacey, S. F., La Rosa, C., Longmate, J., Buck, C., Siliciano, R. F., Diamond, D. J. (2003). Immunization with Th-CTL Fusion Peptide and Cytosine-Phosphate-Guanine DNA in Transgenic HLA-A2 Mice Induces Recognition of HIV-Infected T Cells and Clears Vaccinia Virus Challenge. J. Immunol. 171: 4028-4039 [Abstract] [Full Text]  
• Shen, X., Wong, S. B. J., Buck, C. B., Zhang, J., Siliciano, R. F. (2002). Direct Priming and Cross-Priming Contribute Differentially to the Induction of CD8+ CTL Following Exposure to Vaccinia Virus Via Different Routes. J. Immunol. 169: 4222-4229 [Abstract] [Full Text]  
• Golovina, T. N., Wherry, E. J., Bullock, T. N. J., Eisenlohr, L. C. (2002). Efficient and Qualitatively Distinct MHC Class I-Restricted Presentation of Antigen Targeted to the Endoplasmic Reticulum. J. Immunol. 168: 2667-2675 [Abstract] [Full Text]  
• Rimoldi, D., Muehlethaler, K., Salvi, S., Valmori, D., Romero, P., Cerottini, J.-C., Levy, F. (2001). Subcellular Localization of the Melanoma-associated Protein Melan-AMART-1 Influences the Processing of Its HLA-A2-restricted Epitope. J. Biol. Chem. 276: 43189-43196 [Abstract] [Full Text]  
• Rinaldi, M., Ria, F., Parrella, P., Signori, E., Serra, A., Ciafrè, S. A., Vespignani, I., Lazzari, M., Farace, M. G., Saglio, G., Fazio, V. M. (2001). Antibodies Elicited by Naked DNA Vaccination against the Complementary-determining Region 3 Hypervariable Region of Immunoglobulin Heavy Chain Idiotypic Determinants of B-lymphoproliferative Disorders Specifically React with Patients' Tumor Cells. Cancer Res. 61: 1555-1562 [Abstract] [Full Text]  
• Buck, C. B., Shen, X., Egan, M. A., Pierson, T. C., Walker, C. M., Siliciano, R. F. (2001). The Human Immunodeficiency Virus Type 1 gag Gene Encodes an Internal Ribosome Entry Site. J. Virol. 75: 181-191 [Abstract] [Full Text]  
• Delogu, G., Howard, A., Collins, F. M., Morris, S. L. (2000). DNA Vaccination against Tuberculosis: Expression of a Ubiquitin-Conjugated Tuberculosis Protein Enhances Antimycobacterial Immunity. Infect. Immun. 68: 3097-3102 [Abstract] [Full Text]  
• Lopez, D., Gil-Torregrosa, B. C., Bergmann, C., Del Val, M. (2000). Sequential Cleavage by Metallopeptidases and Proteasomes Is Involved in Processing HIV-1 ENV Epitope for Endogenous MHC Class I Antigen Presentation. J. Immunol. 164: 5070-5077 [Abstract] [Full Text]  
• Chen, C.-H., Wang, T.-L., Hung, C.-F., Yang, Y., Young, R. A., Pardoll, D. M., Wu, T-C. (2000). Enhancement of DNA Vaccine Potency by Linkage of Antigen Gene to an HSP70 Gene. Cancer Res. 60: 1035-1042 [Abstract] [Full Text]  
• Gileadi, U., Moins-Teisserenc, H. T., Correa, I., Booth, B. L. Jr., Dunbar, P. R., Sewell, A. K., Trowsdale, J., Phillips, R. E., Cerundolo, V. (1999). Generation of an Immunodominant CTL Epitope Is Affected by Proteasome Subunit Composition and Stability of the Antigenic Protein. J. Immunol. 163: 6045-6052 [Abstract] [Full Text]  
• Wherry, E. J., Puorro, K. A., Porgador, A., Eisenlohr, L. C. (1999). The Induction of Virus-Specific CTL as a Function of Increasing Epitope Expression: Responses Rise Steadily Until Excessively High Levels of Epitope Are Attained. J. Immunol. 163: 3735-3745 [Abstract] [Full Text]  
• Shi, W., Bu, P., Liu, J., Polack, A., Fisher, S., Qiao, L. (1999). Human Papillomavirus Type 16 E7 DNA Vaccine: Mutation in the Open Reading Frame of E7 Enhances Specific Cytotoxic T-Lymphocyte Induction and Antitumor Activity. J. Virol. 73: 7877-7881 [Abstract] [Full Text]  
• Ben-Shahar, S., Komlosh, A., Nadav, E., Shaked, I., Ziv, T., Admon, A., DeMartino, G. N., Reiss, Y. (1999). 26 S Proteasome-mediated Production of an Authentic Major Histocompatibility Class I-restricted Epitope from an Intact Protein Substrate. J. Biol. Chem. 274: 21963-21972 [Abstract] [Full Text]  
• Ferris, R. L., Hall, C., Sipsas, N. V., Safrit, J. T., Trocha, A., Koup, R. A., Johnson, R. P., Siliciano, R. F. (1999). Processing of HIV-1 Envelope Glycoprotein for Class I-Restricted Recognition: Dependence on TAP1/2 and Mechanisms for Cytosolic Localization. J. Immunol. 162: 1324-1332 [Abstract] [Full Text]  
• Tobery, T., Siliciano, R. F. (1999). Cutting Edge: Induction of Enhanced CTL-Dependent Protective Immunity In Vivo by N-End Rule Targeting of a Model Tumor Antigen. J. Immunol. 162: 639-642 [Abstract] [Full Text]  
• Selby, M., Erickson, A., Dong, C., Cooper, S., Parham, P., Houghton, M., Walker, C. M. (1999). Hepatitis C Virus Envelope Glycoprotein E1 Originates in the Endoplasmic Reticulum and Requires Cytoplasmic Processing for Presentation by Class I MHC Molecules. J. Immunol. 162: 669-676 [Abstract] [Full Text]  
• Lohnas, G. L., Roberts, S. F., Pilon, A., Tramontano, A. (1998). Epitope-Specific Antibody and Suppression of Autoantibody Responses Against a Hybrid Self Protein. J. Immunol. 161: 6518-6525 [Abstract] [Full Text]  
• Gil-Torregrosa, B. C., Raul Castano, A., Del Val, M. (1998). Major Histocompatibility Complex Class I Viral Antigen Processing in the Secretory Pathway Defined by the trans-Golgi Network Protease Furin. JEM 188: 1105-1116 [Abstract] [Full Text]  
• Anton, L. C., Snyder, H. L., Bennink, J. R., Vinitsky, A., Orlowski, M., Porgador, A., Yewdell, J. W. (1998). Dissociation of Proteasomal Degradation of Biosynthesized Viral Proteins from Generation of MHC Class I-Associated Antigenic Peptides. J. Immunol. 160: 4859-4868 [Abstract] [Full Text]  
• Chow, Y.-H., Chiang, B.-L., Lee, Y.-L., Chi, W.-K., Lin, W.-C., Chen, Y.-T., Tao, M.-H. (1998). Development of Th1 and Th2 Populations and the Nature of Immune Responses to Hepatitis B Virus DNA Vaccines Can Be Modulated by Codelivery of Various Cytokine Genes. J. Immunol. 160: 1320-1329 [Abstract] [Full Text]  
• Ben-Shahar, S., Cassouto, B., Novak, L., Porgador, A., Reiss, Y. (1997). Production of a Specific Major Histocompatibility Complex Class I-restricted Epitope by Ubiquitin-dependent Degradation of Modified Ovalbumin in Lymphocyte Lysate. J. Biol. Chem. 272: 21060-21066 [Abstract] [Full Text]  
• Emmerich, N. P. N., Nussbaum, A. K., Stevanovic, S., Priemer, M., Toes, R. E. M., Rammensee, H.-G., Schild, H. (2000). The Human 26 S and 20 S Proteasomes Generate Overlapping but Different Sets of Peptide Fragments from a Model Protein Substrate. J. Biol. Chem. 275: 21140-21148 [Abstract] [Full Text]  
• Mulder, L. C. F., Muesing, M. A. (2000). Degradation of HIV-1 Integrase by the N-end Rule Pathway. J. Biol. Chem. 275: 29749-29753 [Abstract] [Full Text]  
• Tellam, J., Sherritt, M., Thomson, S., Tellam, R., Moss, D. J., Burrows, S. R., Wiertz, E., Khanna, R. (2001). Targeting of EBNA1 for Rapid Intracellular Degradation Overrides the Inhibitory Effects of the Gly-Ala Repeat Domain and Restores CD8+ T Cell Recognition. J. Biol. Chem. 276: 33353-33360 [Abstract] [Full Text]  
• Xiang, R., Lode, H. N., Chao, T.-H., Ruehlmann, J. M., Dolman, C. S., Rodriguez, F., Whitton, J. L., Overwijk, W. W., Restifo, N. P., Reisfeld, R. A. (2000). An autologous oral DNA vaccine protects against murine melanoma. Proc. Natl. Acad. Sci. USA 97: 5492-5497 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS